These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 24338712)

  • 1. N-acetyltransferase 2 genetic variants confer the susceptibility to head and neck carcinoma: evidence from 23 case-control studies.
    Zhang L; Xiang Z; Hao R; Li R; Zhu Y
    Tumour Biol; 2014 Apr; 35(4):3585-95. PubMed ID: 24338712
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NAT2 polymorphisms with oral carcinoma susceptibility: a meta-analysis.
    Zhuo XL; Ling JJ; Zhou Y; Zhao HY; Song YF; Tan YH
    Mol Biol Rep; 2012 Sep; 39(9):8813-9. PubMed ID: 22722991
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of
    Mohammadi H; Roochi MM; Sadeghi M; Garajei A; Heidar H; Ghaderi B; Tadakamadla J; Meybodi AA; Dallband M; Mostafavi S; Mostafavi M; Salehi M; Sadeghi-Bahmani D; Brand S
    Medicina (Kaunas); 2021 Oct; 57(10):. PubMed ID: 34684132
    [No Abstract]   [Full Text] [Related]  

  • 4. Does CYP2E1 RsaI/PstI polymorphism confer head and neck carcinoma susceptibility?: A meta-analysis based on 43 studies.
    Zhuo X; Song J; Liao J; Zhou W; Ye H; Li Q; Xiang Z; Zhang X
    Medicine (Baltimore); 2016 Oct; 95(43):e5156. PubMed ID: 27787372
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NAT2 polymorphisms combining with smoking associated with breast cancer susceptibility: a meta-analysis.
    Zhang J; Qiu LX; Wang ZH; Wang JL; He SS; Hu XC
    Breast Cancer Res Treat; 2010 Oct; 123(3):877-83. PubMed ID: 20180012
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Possible association of NAT2 polymorphism with laryngeal cancer risk: an evidence-based meta-analysis.
    Ying XJ; Dong P; Shen B; Wang J; Wang S; Wang G
    J Cancer Res Clin Oncol; 2011 Nov; 137(11):1661-7. PubMed ID: 21877196
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NAT2 slow acetylation genotypes contribute to asthma risk among Caucasians: evidence from 946 cases and 1,091 controls.
    Wang Y; Zhang Q; Zhang M; Wang C
    Mol Biol Rep; 2014 Mar; 41(3):1849-55. PubMed ID: 24442317
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NAT2 slow acetylation, GSTM1 null genotype, and risk of bladder cancer: results from the Spanish Bladder Cancer Study and meta-analyses.
    García-Closas M; Malats N; Silverman D; Dosemeci M; Kogevinas M; Hein DW; Tardón A; Serra C; Carrato A; García-Closas R; Lloreta J; Castaño-Vinyals G; Yeager M; Welch R; Chanock S; Chatterjee N; Wacholder S; Samanic C; Torà M; Fernández F; Real FX; Rothman N
    Lancet; 2005 Aug 20-26; 366(9486):649-59. PubMed ID: 16112301
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NAT2 polymorphism and lung cancer risk: a meta-analysis.
    Cui D; Wang Z; Zhao E; Ma J; Lu W
    Lung Cancer; 2011 Aug; 73(2):153-7. PubMed ID: 21292342
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NAT2 polymorphisms and susceptibility to anti-tuberculosis drug-induced liver injury: a meta-analysis.
    Wang PY; Xie SY; Hao Q; Zhang C; Jiang BF
    Int J Tuberc Lung Dis; 2012 May; 16(5):589-95. PubMed ID: 22409928
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association Between N-acetyltransferase 2 Polymorphism and Bladder Cancer Risk: Results From Studies of the Past Decade and a Meta-Analysis.
    Wu H; Wang X; Zhang L; Mo N; Lv Z
    Clin Genitourin Cancer; 2016 Apr; 14(2):122-9. PubMed ID: 26585839
    [TBL] [Abstract][Full Text] [Related]  

  • 12. N-acetyltransferase 1 and 2 gene sequence variants and risk of head and neck cancer.
    Demokan S; Suoglu Y; Gözeler M; Demir D; Dalay N
    Mol Biol Rep; 2010 Oct; 37(7):3217-26. PubMed ID: 19898993
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MiR-146a rs2910164 polymorphism and head and neck carcinoma risk: a meta-analysis based on 10 case-control studies.
    Xiang Z; Song J; Zhuo X; Li Q; Zhang X
    Oncotarget; 2017 Jan; 8(1):1226-1233. PubMed ID: 27901485
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vascular endothelial growth factor (VEGF) gene polymorphisms and risk of head and neck cancer: a meta-analysis involving 2,444 individuals.
    Leng WD; He MN; Chen QL; Gong H; Zhang L; Zeng XT
    Mol Biol Rep; 2013 Oct; 40(10):5987-92. PubMed ID: 24057180
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polymorphisms of the XPC gene may contribute to the risk of head and neck cancer: a meta-analysis.
    Zhang Y; Li Z; Zhong Q; Zhou W; Chen X; Chen X; Fang J; Huang Z
    Tumour Biol; 2014 Apr; 35(4):3917-31. PubMed ID: 24338715
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NAT2 polymorphism and gastric cancer susceptibility: a meta-analysis.
    Zhong X; Hui C; Xiao-Ling W; Yan L; Na L
    Arch Med Res; 2010 May; 41(4):275-80. PubMed ID: 20637371
    [TBL] [Abstract][Full Text] [Related]  

  • 17. N-acetyltransferase 2 phenotype and risk of esophageal cancer: a meta analysis.
    Ma RL; Min L; Chen D; Tao WP; Ge W; Wu YG
    Cancer Biomark; 2013 Jan; 13(6):447-55. PubMed ID: 24595082
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Meta-analysis of MMP2, MMP3, and MMP9 promoter polymorphisms and head and neck cancer risk.
    Zhang C; Li C; Zhu M; Zhang Q; Xie Z; Niu G; Song X; Jin L; Li G; Zheng H
    PLoS One; 2013; 8(4):e62023. PubMed ID: 23637955
    [TBL] [Abstract][Full Text] [Related]  

  • 19. No association of TNF-α-308G/A polymorphisms with head and neck cancer risk: A PRISMA-compliant meta-analysis.
    Yuan C; Xu XH; Xu L; Liu Y; Sun M; Ni LH; Wang XL; Chen Z; Zhang K; Zeng G
    Medicine (Baltimore); 2017 Jun; 96(25):e7298. PubMed ID: 28640146
    [TBL] [Abstract][Full Text] [Related]  

  • 20. N-Acetyltransferase 2 genetic polymorphisms and risk of colorectal cancer.
    da Silva TD; Felipe AV; de Lima JM; Oshima CT; Forones NM
    World J Gastroenterol; 2011 Feb; 17(6):760-5. PubMed ID: 21390146
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.